Please turn JavaScript on

ONC

Want to know the latest news and articles posted on ONC?

Then subscribe to their feed now! You can receive their updates by email, via mobile or on your personal news page on this website.

See what they recently published below.

Website title: Oncologynewscentral.com

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  1.4 / day

Message History

Monica N. Fornier, MD, and Robert. A Figlin, MD, discuss when to test for ESR1 mutations and how to choose among three oral SERDs in ER-positive metastatic breast cancer.

Read full story
Imlunestrant plus abemaciclib adds an all-oral option for ESR1-mutated breast cancer, but toxicity, patient selection, and sequencing questions remain.

Read full story
A phase 3 trial found that adding intismeran, an individualized neoantigen therapy, to pembrolizumab significantly improved RFS in resected melanoma.

Read full story
The FDA approved giredestrant (Wilserdly) plus everolimus for adults with ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer.

Read full story
Oncologists at the NCODA Fall Summit say community practices do not need academic-level infrastructure to deliver new therapies, just the right team.

Read full story